医用臭氧作为数字减影成像子宫输卵管造影对比剂的可行性研究

发布时间：2018-04-28 07:11

本文选题：数字减影成像 + 子宫输卵管造影　；参考：《临床放射学杂志》2015年01期

【摘要】：目的探讨医用臭氧(O3)作为数字减影成像(DSI)子宫输卵管造影(HSG)对比剂的可行性。方法随机选择226例拟行DSI-HSG的病例,医用O3组113例,对比剂选用浓度30μg/ml的O3;碘对比剂组113例,对比剂选用320 mg I/ml碘佛醇注射液。分别进行DSA采集成像,对两组DSA图像质量评分采用Wilcoxon秩和检验,输卵管通畅程度造影表现比较采用χ2检验。结果 O3组、碘佛醇组共226例,输卵管448条。造影术中、术后无一例发生严重并发症。O3组图像质量优、良、差、采集失败者分别为83.2%、11.5%、3.5%、1.8%,碘佛醇组图像质量优、良、差、采集失败者分别为86.7%、10.6%、2.7%、0%,两组图像质量无显著性差异(Z=0.805,P=0.421)。O3组225条输卵管,近段堵塞78条、中远段堵塞34条、通而不畅90条、完全通畅23条;碘佛醇组223条输卵管,近段堵塞81条、中远段堵塞33条、通而不畅89条、完全通畅20条;两组输卵管通畅程度造影表现差异没有统计学意义(P0.05)。结论医用O3作为DSI-HSG对比剂是可行的。
[Abstract]:Objective to investigate the feasibility of medical ozone O 3 as a contrast agent for hysterosalpingography (HSG) in digital subtraction imaging (DSI). Methods A total of 226 patients with DSI-HSG were randomly selected, 113 patients in the medical O 3 group were treated with 30 渭 g/ml O 3, and 113 cases in the iodine contrast group were treated with 320 mg I/ml iodoferol injection. The quality of DSA images in the two groups was evaluated by Wilcoxon rank sum test, and the oviduct patency degree was compared by 蠂 2 test. Results there were 226 cases in O 3 group and iodover alcohol group with 448 oviducts. In contrast, there was no serious complication after operation. The image quality of group O3 was excellent, good, poor, and the number of losers were 83.2 and 11.53.5and 1.8.The image quality of iodoverol group was excellent, good and poor. There was no significant difference in the image quality between the two groups. There was no significant difference in image quality between the two groups. There were 225 oviducts in group Z 0.805, 78 in proximal segment, 34 in distal segment, 90 in middle and distal segments, and 23 in complete patency, and 223 fallopian tubes in iodophore group, 81 in proximal segment. 33 of them were blocked in the middle and distal segment, 89 were blocked, 20 were completely patency, and there was no significant difference in the degree of tubal patency between the two groups (P 0.05). Conclusion it is feasible to use O 3 as DSI-HSG contrast agent.
【作者单位】：武汉大学人民医院放射科;
【分类号】：R816.91

【参考文献】